Saint Louis, MO · Founded 2007 · Privately Held (backing)
Provider of specialty diagnostic testing services intended to offer novel diagnostics for Alzheimer's disease. C2N Diagnostics is based in Saint Louis, MO and was founded in 2007. It has raised $95 million across 2 recorded rounds; the latest was a $10 million early-stage round in May 2025.
Last price · $/share
—
Implied valuation
—
Total raised
$95.0M
Last round
Early Stage VC
May 2025
No prints on record
No secondary trades in C2N Diagnostics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of C2N Diagnostics with a free account
·Watch C2N Diagnostics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of C2N Diagnostics stock.
